Belgian biotech company Agomab Therapeutics raises €94.9M to tackle fibrosis; here's how
Ghent, Belgium-based Agomab Therapeutics, a biotech company, announced on Wednesday that it has closed a $100M (approximately €94.9M).
Source: siliconcanals.com